Shareholders approve CVS Health's $69B acquisition of Aetna

CVS Health and Aetna shareholders have overwhelmingly approved the drug store chain's proposed acquisition of the insurer, according to CNBC.

In December, CVS Health entered into a definitive agreement to acquire all outstanding shares of Aetna for approximately $69 billion in cash and stock.

At a special meeting March 13, 98 percent of CVS shareholders' ballots were in favor of the transaction. Among Aetna shareholders, about 97 percent of votes cast were in favor of the deal.

The parties expect the transaction, which still needs approval from the Department of Justice, to close in the second half of 2018.

More articles on payer issues:

UnitedHealth taps former GlaxoSmithKline CEO to lead Optum: 4 things to know
Some Anthem patients afraid to use ED under new policy: 6 things to know
How health insurers game Medicare Advantage ratings to boost bonus payments

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months